Mental health conditions are the leading underlying cause of pregnancy-related death. In our mission to address the worldwide mental health crisis, we're advancing RE104 for underserved #mentalhealth disorders, beginning with #postpartumdepression . #MaternalMentalHealth

We are proud to recognize #MMHWeek2024 . Our team is passionate about supporting the #postpartumdepression community as we advance RE104, our proprietary, clinical-stage serotonergic #psychedelic drug candidate for underserved #mentalhealth disorders, beginning with #PPD .

We’re excited to announce the closing of our $103M Series A financing co-led by MPM BioImpact Capital and Novo Holdings. This will support the RECONNECT Phase 2 clinical trial for RE104 in #PPD and expansion into other psychiatric indications. Learn more: bit.ly/3Wj5fyF

We’re excited to announce that the clinical dataset from our Phase 1 study of lead asset, RE104, will be presented in both a podium and poster at the Anxiety and Depression Association of America 2024 Conference taking place April 11-14. Learn more: bit.ly/49seKhH

#PPD
#ADAA2024

Breaking: Reunion has entered into a definitive arrangement agreement with MPM BioImpact Capital, a world-leading #biotech #investment firm, whereby MPM affiliates would acquire Reunion in an all-cash transaction valued at approximately $13.1 million. Full story: bit.ly/45zSguJ

#DYK ? When communities invest in women, they reinvest up to 90% of their earnings back into their families & the ripple effects reach far beyond the individual. Today, we celebrate International Day of Action on Women's Health as we pioneer the future of #womenshealth together.

Our CSO, Nathan Bryson, joined @The_GreenRush podcast this week to share details on his journey with Reunion, our unique serotonergic #psychedelic compound developed to treat #postpartumdepression , Company goals and more. Tune in for the episode: bit.ly/3MxPiy0 $REUN

This year’s #MentalHealthAwarenessMonth campaign calls for individuals to “look around, look within” to examine how different factors, such as environment, gender, socioeconomic status & genetics, can deeply influence one’s predisposition to developing mental health challenges.

Mother’s Day kicks off the 21st annual #NationalWomensHealthWeek , with the theme of Women’s Health, Whole Health: Prevention, Care & Wellbeing, which spotlights the often undervalued holistic wellness of women - mental & physical. Learn more from CDC: bit.ly/3LQXN89

#WomensHealthCareMonth was first established by NCCC & is pioneered by the HHS.gov Office on Women's Health with the goal of empowering women to make their health a priority. Learn about the history and mission behind this month of activism: bit.ly/3LzPb5T

Today is #WorldMaternalMentalHealthDay in recognition of the alarming percentage of mothers who suffer from perinatal mood & anxiety disorders during pregnancy & within the first 12 months after childbirth. For resources & to get involved, visit ICP Care: bit.ly/3HhvJID

Reunion is proud to advocate for #WomensHealthCareMonth , #MentalHealthAwarenessMonth & #NationalAnxietyMonth ! Stay tuned as we surface stats & resources this month in the fight to improve mental health for all through the power of #psychedelic -assisted treatment alternatives.

Serotonergic #psychedelic treatment offers a unique mechanism of action with a fast onset, high response rates, fewer adverse events than traditional #antidepressants and durable outcomes that last beyond dose exposure. Explore our novel molecules: bit.ly/3SGIkt6 $REUN

The mechanistic phases of our serotonergic molecules feature a two-pronged efficacy profile: Acute effects that occur in a monitored clinical environment & durable effects that are realized post-dose during integration to a “new normal.” Learn more: bit.ly/3SGIkt6 $REUN

#DYK ? Antidepressants, commonly used to treat #PPD , can take weeks for efficacy to set in. We are advancing psychedelic-inspired novel drug candidates to target serotonin & deliver safe, fast-acting, short duration therapies to patients underserved by traditional therapies. $REUN

Reunion is pushing the boundaries of traditional medicine in the pursuit to develop safe, accessible #mentalhealth therapeutics for patient populations facing a critically under-resourced and underserved healthcare landscape. Get to know our mission: bit.ly/3kO53qC $REUN

#ICYMI : Our President & CEO Greg presented at the Oppenheimer & Co. Inc. Health Conference to discuss our approach to creating innovative tools to combat the global mental health crisis. Check out his presentation for an in-depth look at Reunion's story: bit.ly/3KF1nBO $REUN

Today, we celebrate #WorldHealthDay in observance of World Health Organization (WHO)’S 75th anniversary. This year’s theme is #HealthForAll , a tribute to the advancements made in healthcare accessibility and the global leaders that pioneer medicine, #biotech and public health for all patient populations.